
By DONALD G. McNEIL Jr. from NYT Health The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives. https://nyti.ms/2VRY6qm
Hiç yorum yok:
Yorum Gönder